Literature DB >> 30228163

Donor-funded research: permissible, not perfect.

Mike King1, Angela Ballantyne1,2.   

Abstract

Donor-funded research is research funded by private donors in exchange for research-related benefits, such as trial participation or access to the trial intervention. This has been pejoratively referred to as 'pay to play' research, and criticised as unethical. We outline three models of donor-funded research, and argue for their permissibility on the grounds of personal liberty, their capacity to facilitate otherwise unfunded health research and their consistency with current ethical standards for research. We defend this argument against objections that donor-funded research is wrongly exploitative, unfair and undermines the public good of medical research. Our conclusion is that, like all human subjects research, donor-funded research should be regulated via standard health research legislation/guidelines and undergo Research Ethics Committee/Institutional Review Board and scientific peer-review. We expect that, measured against these standards, some donor-funded research would be acceptable. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical trials; drugs and drug industry; ethics committees/consultation; research ethics; research on special populations

Mesh:

Year:  2018        PMID: 30228163     DOI: 10.1136/medethics-2018-104966

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  2 in total

1.  Mitigating Ethical Risks in Public-Private Partnerships in Public Health.

Authors:  Diana M Yassanye; Andrea P Anason; Drue H Barrett
Journal:  J Public Health Manag Pract       Date:  2021 Jul-Aug 01

2.  Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers.

Authors:  Kirstie Shearman; Alexander Masters; Dominic Nutt; Simon Bowman; Heather Draper
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.